Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://journals.lww.com/hep/abstract/2003/01000/activated_stellate_cells_express_the_trail.16.aspx, but it redirected us to https://journals.lww.com/hep/abstract/2003/01000/activated_stellate_cells_express_the_trail.16.aspx. The analysis below is for the second page.

Title[redir]:
Hepatology
Description:
ivated cell types are more sensitive than their quiescent phenotypes to apoptosis by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), we examined the expression of TRAIL death receptors (DRs) and susceptibility to TRAIL cytotoxicity in stellate cells undergoing progressive activation. A spontaneously immortalized human stellate cell line, LX-2, was analyzed during 14 days of progressive activation following plating, during which time Ξ±-smooth muscle actin (Ξ±-SMA) and a Ξ²-crystallin (markers of stellate cell activation) messenger RNA (mRNA) increased 7-fold and 5-fold, respectively. During this same interval, TRAIL-R1/DR4 and TRAIL-R2/DR5 mRNA expression increased 18-fold and 17.6-fold, although TRAIL-R2/DR5 expression was quantitatively 103-fold greater than TRAIL-R1/DR4; parallel changes occurred in TRAIL/DR5 protein expression and cellular susceptibility to TRAIL-mediated apoptosis. Similar findings were observed in primary murine stellate cells undergoing activation on a plastic surface. In conclusion, stellate cells show activation-dependent TRAIL-R2/DR5 expression and TRAIL-mediated apoptosis. Because TRAIL-R2/DR5 is not expressed by hepatocytes, TRAIL/DR5 agonists may be useful in reducing fibrosis by inducing stellate cell apoptosis. E-mail:[email protected] *Address reprint requests to: Mayo Medical School, Clinic, and Foundation, 200 First St. SW, Rochester, MN 55905. Fax: 507-284-0762. Received August 19, 2002; Accepted September 30, 2002; previously published online December 30, 2003 Copyright Β© 2003 American Association for the Study of Liver Diseases....

Matching Content Categories {πŸ“š}

  • Education
  • Telecommunications
  • Video & Online Content

Content Management System {πŸ“}

What CMS is doi.org built with?


Doi.org is powered by MYBB.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We don’t know how the website earns money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {πŸ”}

stellate, cells, apoptosis, trailrdr, aasld, expression, fold, liver, log, journal, activated, trail, cell, activation, access, hepatology, subscribe, issue, alerts, abstract, trailmediated, register, member, logo, articles, browse, submit, buy, fibrosis, quiescent, susceptibility, undergoing, progressive, mrna, increased, traildr, copyright, american, association, study, diseases, text, subscribers, members, request, content, service, usa, privacy, policy,

Topics {βœ’οΈ}

trail-r2/dr5 expression trail/dr5 protein expression trail receptor-2/death receptor-5 trail-r2/dr5 aasld members log stellate cell activation activated stellate cells trail/dr5 agonists open access policy trail-mediated apoptosis liver diseases trail death receptors activated cell types individual subscribers log trail-r1/dr4 institutional users access artificial intelligence training quantitatively 103-fold greater progressive activation full text access increased 7-fold journal tables register subscribe service request 800-638-3030 trail cytotoxicity Ξ±-sma expression journal website subscribe important mechanism reduce numbers resolution phase hepatic fibrosis observations suggest apoptotic stimuli quiescent counterparts quiescent phenotypes Ξ²-crystallin messenger rna mrna similar findings plastic surface reducing fibrosis email inbox rights reserved data mining trail apoptosis issue cellular susceptibility

Questions {❓}

  • AASLD Member?
  • Not a Subscriber?

External Links {πŸ”—}(66)

Analytics and Tracking {πŸ“Š}

  • Comscore
  • Google Analytics
  • Google Tag Manager
  • Mouseflow

Libraries {πŸ“š}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Video.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Cookielaw
  • Jsdelivr
  • Mouseflow
  • Scite
  • Wolterskluwer

5.53s.